Boschiero C, Beshah E, Bakshi M, Miramontes E, Hebert D, Thompson P
Int J Mol Sci. 2025; 26(5).
PMID: 40076885
PMC: 11900041.
DOI: 10.3390/ijms26052264.
Wootton L, Morgan E
Oncogene. 2025; 44(11):713-723.
PMID: 40011575
PMC: 11888991.
DOI: 10.1038/s41388-025-03310-6.
Schmidt H, Horner S
Viruses. 2025; 17(2).
PMID: 40007042
PMC: 11861903.
DOI: 10.3390/v17020287.
Yoon J, Kim K, Cho S, Cho M, Park S, Hwang D
Nat Commun. 2025; 16(1):1962.
PMID: 40000667
PMC: 11861895.
DOI: 10.1038/s41467-025-57237-3.
Singh D, Ahmed M, Akter S, Shivanna V, Bucsan A, Mishra A
Nat Commun. 2025; 16(1):1957.
PMID: 40000643
PMC: 11861635.
DOI: 10.1038/s41467-025-57090-4.
Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates.
Jadhav P, Liang X, Ansari A, Tan B, Tan H, Li K
Nat Commun. 2025; 16(1):1604.
PMID: 39948104
PMC: 11825904.
DOI: 10.1038/s41467-025-56902-x.
Analysis of Structures of SARS-CoV-2 Papain-like Protease Bound with Ligands Unveils Structural Features for Inhibiting the Enzyme.
Varghese A, Liu J, Liu B, Guo W, Dong F, Patterson T
Molecules. 2025; 30(3).
PMID: 39942596
PMC: 11820935.
DOI: 10.3390/molecules30030491.
Viral tolerance enabled by a bat-specific genomic tweak.
Zhu J, Gack M
Nature. 2025; 638(8050):326-327.
PMID: 39881171
DOI: 10.1038/d41586-025-00081-8.
Bat genomes illuminate adaptations to viral tolerance and disease resistance.
Morales A, Dong Y, Brown T, Baid K, Kontopoulos D, Gonzalez V
Nature. 2025; 638(8050):449-458.
PMID: 39880942
PMC: 11821529.
DOI: 10.1038/s41586-024-08471-0.
Sphingolipid metabolism orchestrates establishment of the hair follicle stem cell compartment.
Peters F, Hofs W, Lee H, Brodesser S, Kruse K, Drexler H
J Cell Biol. 2025; 224(4).
PMID: 39879198
PMC: 11778283.
DOI: 10.1083/jcb.202403083.
Proteomics and transcriptomics combined reveal specific immunological markers in autoimmune thyroid disease.
Chen X, Chen H
Front Immunol. 2025; 15:1531402.
PMID: 39872521
PMC: 11769792.
DOI: 10.3389/fimmu.2024.1531402.
Site-selective photo-crosslinking for the characterisation of transient ubiquitin-like protein-protein interactions.
Sandy Z, Wang Z, Behera D, Foster B, Martin F, Bruninghoff K
PLoS One. 2025; 20(1):e0316321.
PMID: 39869599
PMC: 11771908.
DOI: 10.1371/journal.pone.0316321.
Interferon-Stimulated Genes and Immune Metabolites as Broad-Spectrum Biomarkers for Viral Infections.
Huang C, Laurent-Rolle M, Grove T, Hsu J
Viruses. 2025; 17(1).
PMID: 39861921
PMC: 11768885.
DOI: 10.3390/v17010132.
Chemical tools to define and manipulate interferon-inducible Ubl protease USP18.
Davis G, Omole A, Jung Y, Rut W, Holewinski R, Suazo K
Nat Commun. 2025; 16(1):957.
PMID: 39843430
PMC: 11754618.
DOI: 10.1038/s41467-025-56336-5.
ISG15-LFA1 interactions in latent HIV clearance: mechanistic implications in designing antiviral therapies.
Koka P, Ramdass B
Front Cell Dev Biol. 2025; 12():1497964.
PMID: 39810915
PMC: 11729345.
DOI: 10.3389/fcell.2024.1497964.
METTL3-Mediated m6A Modification of ISG15 mRNA Regulates Doxorubicin-Induced Endothelial Cell Apoptosis.
Jian D, Li H, Wang C, Li F, Li R, Jin S
J Cell Mol Med. 2025; 29(1):e70339.
PMID: 39789417
PMC: 11717669.
DOI: 10.1111/jcmm.70339.
Bovine Lactoferrin Enhances Toll-like Receptor 7 Response in Plasmacytoid Dendritic Cells and Modulates Cellular Immunity.
Yago T, Tada A, Kubo S, Oda H, Iwabuchi S, Tanaka M
Int J Mol Sci. 2025; 25(24.
PMID: 39769133
PMC: 11676446.
DOI: 10.3390/ijms252413369.
Multiorgan proteomic analysis of infected animal models predict potential host factors for chikungunya virus.
Lin D, Tang C, Wang J, Yang Y, Yang H, Zhou Y
MedComm (2020). 2025; 6(1):e70013.
PMID: 39764561
PMC: 11702418.
DOI: 10.1002/mco2.70013.
Characteristics of viral ovarian tumor domain protease from two emerging orthonairoviruses and identification of Yezo virus human infections in northeastern China as early as 2012.
Chen Z, Zhang J, He P, Xiong T, Zhu D, Zhu W
J Virol. 2025; 99(2):e0172724.
PMID: 39745436
PMC: 11852922.
DOI: 10.1128/jvi.01727-24.
A cell-based Papain-like Protease (PLpro) activity assay for rapid detection of active SARS-CoV-2 infections and antivirals.
Jimenez-Campos A, Maestas L, Velappan N, Beck B, Ye C, Wernsing K
PLoS One. 2024; 19(12):e0309305.
PMID: 39724215
PMC: 11670956.
DOI: 10.1371/journal.pone.0309305.